OTC & Nutraceuticals Europe

Europe Smoking Cessation Products Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Europe Smoking Cessation Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Europe · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $844.8 Mn Placeholder estimate
Estimate 2025 $876.9 Mn 19.9% of the global market
Projected 2034 $1.23 Bn 39.9% Adds $349.8 Mn over 9 forecast years
CAGR 2025–2034 3.8% Faster than 12% of 83 OTC & Nutraceuticals markets here
Key players 5
  • Europe is 19.89% of the global market.
  • Among regions, the largest is North America at $2.19 Bn.
  • Fastest growing: Latin America at 6.1% a year.
  • Europe ranks 3rd of 6 by size among regions.

Market size projection

Europe

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$349.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Smoking Cessation Products Market market size by year, Europe
YearMarket sizeChange that yearSince 2025
2024 (estimate) $844.8 Mn — —
2025 (base) $876.9 Mn +$32.1 Mn —
2026 (forecast) $910.3 Mn +$33.3 Mn +3.8%
2027 (forecast) $944.8 Mn +$34.6 Mn +7.7%
2028 (forecast) $980.7 Mn +$35.9 Mn +11.8%
2029 (forecast) $1.02 Bn +$37.3 Mn +16.1%
2030 (forecast) $1.06 Bn +$38.7 Mn +20.5%
2031 (forecast) $1.10 Bn +$40.2 Mn +25.1%
2032 (forecast) $1.14 Bn +$41.7 Mn +29.8%
2033 (forecast) $1.18 Bn +$43.3 Mn +34.8%
2034 (forecast) $1.23 Bn +$44.9 Mn +39.9%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Europe Smoking Cessation Products Market Analysis at a glance
Market size, 2025$876.9 Mn placeholder estimate
Forecast, 2034$1.23 Bn placeholder estimate
Growth (CAGR), 2025–20343.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, form and distribution channel (see all)
Key playersHaleon PLC, Johnson & Johnson, Pfizer Inc., Perrigo Company plc, Cipla Inc. (see all)
Regulator in EuropeEMA and EFSASource: European Medicines Agency. Checked 14 Nov 2026.Source: European Food Safety Authority. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Europe Smoking Cessation Products Market Analysis Executive Summary

Smoking cessation products help people quit smoking, including nicotine patches, gums, sprays, medicines and quit apps.

Key segments of the smoking Cessation Products market include product (Nicotine Replacement Therapy, Prescription Drugs and Digital Quit Programs) and form (Patches, Gum and Lozenges and Sprays and Inhalers).

Bar chart: Europe Smoking Cessation Products market size, 2024–2034, placeholder estimates. $844.8 Mn in 2024, $876.9 Mn in 2025 and $1.23 Bn in 2034, 3.8% CAGR.
Europe Smoking Cessation Products market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Europe Smoking Cessation Products Market Dynamics

Market Growth Drivers

More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the smoking Cessation Products market.

Opportunity

Ready-to-use formulations, biosimilars and supply security programmes give the smoking Cessation Products market room to grow.

Market Restraints

Drug shortages, price controls, generic competition and strict hospital budgets hold back the smoking Cessation Products market.

Competitive Landscape for Smoking Cessation Products Market in Europe

The smoking Cessation Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Smoking Cessation Products Market in Europe

Smoking Cessation Products in Europe: rules

In the EU, many new medicines are authorised once for every member state by the European Commission, after review by the European Medicines Agency (EMA).⁠[1] In the countries we cover here, medicines are approved by ANSM (France)⁠[2], BfArM (Germany)⁠[3], AIFA (Italy)⁠[4], Ministry of Health (Russia)⁠[5], AEMPS (Spain)⁠[6], MHRA (UK)⁠[7], CBG-MEB (Netherlands)⁠[8], FAMHP (Belgium)⁠[9], Swissmedic (Switzerland)⁠[10], Läkemedelsverket (Sweden)⁠[11], Danish Medicines Agency (Denmark)⁠[12], URPL (Poland)⁠[13] and TITCK (Turkey)⁠[14]. EU law sets common rules for food supplements, and the European Food Safety Authority (EFSA) assesses their health claims.⁠[15] In the countries we cover here, supplement rules come from DGCCRF and ANSES (France)⁠[16], BVL (Germany)⁠[17], Ministry of Health (Italy)⁠[18], Rospotrebnadzor (Russia)⁠[19], AESAN (Spain)⁠[20], FSA (UK)⁠[21], NVWA (Netherlands)⁠[22], FPS Public Health (Belgium)⁠[23], FSVO (Switzerland)⁠[24], Livsmedelsverket (Sweden)⁠[25], Danish Veterinary and Food Administration (Denmark)⁠[26], GIS (Poland)⁠[27] and Ministry of Agriculture and Forestry (Turkey)⁠[28].

[1] European Medicines Agency. Checked 14 Nov 2026.

[2] ANSM, French medicines agency. Checked 14 Nov 2026.

[3] Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.

[4] Italian Medicines Agency (AIFA). Checked 14 Nov 2026.

[5] Ministry of Health of the Russian Federation. Checked 14 Nov 2026.

[6] Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.

[7] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.

[8] Medicines Evaluation Board (CBG-MEB). Checked 19 Nov 2026.

[9] Federal Agency for Medicines and Health Products (FAMHP). Checked 19 Nov 2026.

[10] Swissmedic. Checked 19 Nov 2026.

[11] Swedish Medical Products Agency (Läkemedelsverket). Checked 19 Nov 2026.

[12] Danish Medicines Agency. Checked 19 Nov 2026.

[13] Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL). Checked 19 Nov 2026.

[14] Turkish Medicines and Medical Devices Agency (TITCK). Checked 19 Nov 2026.

[15] European Food Safety Authority. Checked 14 Nov 2026.

[16] ANSES. Checked 14 Nov 2026.

[17] Federal Office of Consumer Protection and Food Safety (BVL). Checked 14 Nov 2026.

[18] Italian Ministry of Health. Checked 14 Nov 2026.

[19] Rospotrebnadzor. Checked 14 Nov 2026.

[20] Spanish Agency for Food Safety and Nutrition (AESAN). Checked 14 Nov 2026.

[21] Food Standards Agency. Checked 14 Nov 2026.

[22] Netherlands Food and Consumer Product Safety Authority (NVWA). Checked 19 Nov 2026.

[23] FPS Public Health, Food Chain Safety and Environment. Checked 19 Nov 2026.

[24] Federal Food Safety and Veterinary Office (FSVO). Checked 19 Nov 2026.

[25] Swedish Food Agency (Livsmedelsverket). Checked 19 Nov 2026.

[26] Danish Veterinary and Food Administration. Checked 19 Nov 2026.

[27] Chief Sanitary Inspectorate (GIS). Checked 19 Nov 2026.

[28] Ministry of Agriculture and Forestry. Checked 19 Nov 2026.

Policy changes and Reimbursement scenario

Food and supplement rules, labelling and health-claim regulations govern smoking Cessation Products products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in Europe.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Smoking Cessation Products right now, from free public sources.

Patients

Smoking (adults), % of adults (World Bank)
CountryValueYear
Belgium23.52024
Denmark15.72024
France33.62024
Germany22.02024
Italy22.42024
Netherlands20.52024
Poland21.72024
Russia27.02024
Spain27.62024
Sweden20.32024
Switzerland23.12024
Turkey31.12024
UK12.82024
Compare every country on the Public Health Dashboard

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 21 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Smoking Cessation Products in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Smoking Cessation Products market in Europe?
Placeholder estimate: about $876.9 Mn in 2025, rising to about $1.23 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Smoking Cessation Products market in Europe growing?
Placeholder estimate: about 3.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Smoking Cessation Products market report cover?
The report splits the market by product (Nicotine Replacement Therapy, Prescription Drugs, Digital Quit Programs), form (Patches, Gum and Lozenges, Sprays and Inhalers, Tablets) and distribution channel (Supermarkets and Hypermarkets, Pharmacies and Drug Stores, Online Retail, Specialty Stores).
Who are the key players in the Smoking Cessation Products market?
Key players include Haleon PLC, Johnson & Johnson, Pfizer Inc., Perrigo Company plc and Cipla Inc..
What is driving the Smoking Cessation Products market?
More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the smoking Cessation Products market.
Who regulates Smoking Cessation Products in Europe?
In the EU, many new medicines are authorised once for every member state by the European Commission, after review by the European Medicines Agency (EMA). EU law sets common rules for food supplements, and the European Food Safety Authority (EFSA) assesses their health claims. Source: European Medicines Agency. Checked 14 Nov 2026. Source: European Food Safety Authority. Checked 14 Nov 2026.
How much research is published on Smoking Cessation Products?
PubMed lists 9,665 papers on Smoking Cessation Products added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related OTC & Nutraceuticals reports in Europe

See all

Related on smoking and respiratory

See the topic